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A clinical pathway represents a plan of care based
on the premise that the treatment of patients with
similar diagnoses can be standardized in an effort to
optimize patient care and eliminate unnecessary
costs. The current paradigm for the postoperative
care of the patient who undergoes aortic surgery
(AS), as reflected in the standard vascular surgery
textbooks and recent publications, assumes the need
for invasive monitoring in the intensive care unit
(ICU) and the development of a paralytic ileus, cul-
minating in a hospital stay of 6 to 10 days.
Accordingly, the hospital related costs and the length
of stay (LOS) associated with open abdominal AS are
regarded as distinct disadvantages when compared
with the transluminal endovascular techniques. This
report is an observational study that reviews the
author’s (P.C.P) recent experience with a postopera-
tive care plan that emphasized early feeding, early
ambulation, and limited use of the ICU in the care of
the patient who undergoes AS, which resulted in a
shorter LOS and reduced expenses. This care plan is
summarized and presented as a clinical pathway.
METHODS
This study is an observational study of the most
recent 50 consecutive patients, who underwent AS
by a single surgeon performed from April 1996
through June 1998, whose postoperative care incor-
porated the clinical pathway discussed herein. The
results are presented and discussed in the context of
other recently published open surgical and endovas-
cular series. To focus specifically on the clinical fac-
tors that are intrinsic to surgery of the infrarenal
aorta without superimposing the variables associated
with procedures involving the renal arteries and the
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Purpose: This paper reports on an experience with a clinical pathway for elective
infrarenal aortic surgery (AS) that targeted hospital discharge on postoperative day
(POD) 3. The pathway incorporated early feeding, early ambulation, and selective use
of the intensive care unit (ICU). 
Methods: A review of 50 consecutive hospital discharges after AS (aneurysm repair and
aortofemoral bypass grafting) by a single surgeon performed from April 1996 through
June 1998 with this clinical pathway is reported. The data collected included morbidity
rate, mortality rate, length of stay (LOS), and number of hospital readmissions.
Results: The average LOS for all patients was 3.0 days. Only six patients (12%) were
admitted to the ICU. Discharge on POD 3 was achieved in 80% of the group (40 of 50),
and increasing experience improved compliance, with 92% of the most recent 25 patients
(23 of 25) being discharged by POD 3. Eleven of these 25 patients (44%) were dis-
charged on POD 2. No patient was readmitted to the hospital within a 30-day period
after discharge. There was no mortality after AS during this period. 
Conclusion: Factors that limit the discharge of patients recovering from AS include the
ability to ambulate independently and to tolerate a diet. Ambulation and feeding on
POD 1 were well tolerated by most patients, which shortened the period of hospitaliza-
tion. Admission to the ICU was infrequently required when a monitored surgical step-
down unit was available. Discharge by POD 3 for AS has been proven to be routinely
achievable, safe, and well accepted by patients and to reduce the cost of hospitalization.
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suprarenal aorta, the clinical spectrum of patients
comprising this report was narrowed to only include
infrarenal abdominal aortic aneurysm repair (AAA)
and aortobifemoral bypass grafting (ABF).
Patients. In this group of 50 patients, 25 pre-
sented with AAAs and 25 presented for treatment of
aortoiliac occlusive disease during a 26-month peri-
od that ended June 1998. Forty-nine of the 50
patients underwent elective operation. There were
34 men (68%) and 16 women (32%). The average
age of the entire group was 64 years, with ages rang-
ing from 40 to 88 years. The average age of the
patients who underwent treatment for AAA was 69
years, and the average age of those patients who
underwent treatment for occlusive disease was 60
years. The incidence rate of clinically significant
coronary artery disease was 48%, of diabetes mellitus
was 6%, of current or recent tobacco use was 74%,
and of hypertension as 52%. Preoperative testing of
known cardiac disease was performed at the discre-
tion of the consulting cardiologist.
Operative technique. All the patients were
admitted on the day of surgery, and all procedures
but one were performed through a standard midline
transperitoneal approach. Standard operative tech-
niques of endoaneurysmal repair of AAA and ABF
with end-to-end aortic anastomoses were used.
Radial artery pressure monitoring was used routine-
ly in the perioperative period. However, pulmonary
artery monitoring was used only in those patients
with severe left ventricular dysfunction and a history
of congestive heart failure and, thus, was used infre-
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Table I. Elective abdominal infrarenal aortic surgery clinical pathway orders
Postoperative POD 1
Assessment and evaluation Vital signs per PACU protocol Vital signs w/vascular 3 q 4h
PACU for a minimum of 3 hours D/C telemetry if no arrythmia
Transfer to department if okay with MD Notify MD of nausea/emesis
Vital signs q 2 h for 4 h then q 4 h with Notify MD for u/o <250 mL/8 h
vascular 3 after transfer to department 
Notify MD for u/o <250 mL/8 h
Telemetry for 24 h
Diagnostics H&H, renal panel CBC, renal panel
O2 titration per protocol O2 titration if on O2
Temperature >101.5° see temperature Temperature >101.5° see temperature protocol
protocol
Procedures IS cough and deep breathe q 1 h IS cough and deep breathe q 1 h
Foley catheter to gravity D/C Foley catheter in morning
If patient is unable to void 8 h after Foley 
catheter D/C, straight catheter
Medications Morphine PCA D/C PCA fi hydrocodone when po
Metaclopramide 10 mg IVPB q 6 h for 4 h
IV D5 1⁄2 NS at 100 mL/h D5 1⁄2 NS at 100 mL/h, D/C when po
Nutrition Sips of clear liquids Clear liquids
Activity Up to chair as tolerated Physical therapy to initiate ambulation
Teaching Reinforce pathway goals Reinforce pathway goals
Pain management Pain management
Pulmonary toilet and IS Pulmonary toilet and IS
Discharge plan Anticipate home care needs Initiate discharge planning
POD, Postoperative day; PACU, postanesthesia care unit; q, every; h, hour; u/o, urine output; 3 , checks; H&H, hematocrit and hemo-
globin; IS, incentive spirometry; PCA, patient-controlled analgesia; IVPB, intravenous piggyback; D/C, discontinue; CBC, complete 
blood cell count; po, per oral; I/O, intake/output; OTA, open to air; prn, as needed.
DISCHARGE GOALS
1. Patient ambulates with little assistance or at preadmission level of activity.
2. Patient is tolerating a regular diet without nausea or vomiting and is passing flatus/stool.
3. Patient is at preadmission respiratory status.
4. Patient temperature is less than 100.5°.
5. Pain is controlled with oral medication.
6. Wound(s) are free of signs of infection. Patient/significant other is able to perform wound care.
7. Patient/significant other verbalizes understanding of discharge instructions and is provided written information.
8. Appropriate care is available at discharge/transfer location. 
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POD 2 POD 3
Vital signs with vascular 3 q 4 h Vital signs with vascular 3 q 4 h
I/O I/O
O2 titration if on O2 Temperature >101.5° see temperature protocol
Temperature >101.5° see temperature protocol
Incision OTA Incision OTA
Wound care Wound care
Bisacodyl supplement if no bowel movement/flatus Cathartic enema if no bowel movement/flatus
Hydrocodone q 4 h po prn pain Hydrocodone q 4 h po prn pain
Saline lock
Advance diet as tolerated Advance to home diet
Up in halls with assistance three times a day Up in halls with assistance three times a day
What to expect at home: lack of appetite, lack of energy What to expect at home: lack of appetite, lack of energy
Discharge planning per patient care coordinator Discharge planning per patient care coordinator
quently. Epidural catheters were not used. In gener-
al, intraoperative nasogastric decompression was
used only if gastric distention was directly observed.
Postoperative clinical pathway. The clinical
pathway is reproduced in Table I, and its key aspects
are reviewed here. The patients underwent extuba-
tion as was appropriate before leaving the operating
room or shortly after arrival in the postanesthesia
care unit (PACU). The patients were observed in
the PACU for a minimum of 3 hours before trans-
fer, if stable, to a monitored department experienced
in the care of patients for cardiothoracic and vascu-
lar surgery. The staffing of these telemetry nursing
units in one hospital (The Christ Hospital) was typ-
ical of a surgical floor nursing unit and in the other
hospital (The Jewish Hospital) was staffed at a
slightly higher level (120%) than a regular floor.
Before transfer to the floor, arterial lines and pul-
monary artery catheters (if used) were removed.
Criteria for transfer to the ICU included the follow-
ing: the need for ventilatory support, the need for
continued invasive monitoring as manifested by
hemodynamic instability, the need for intravenous
pharmacologic control of blood pressure, or the
presence of severe cardiopulmonary disease.
After transfer to the floor, the patients were moni-
tored for a minimum of 24 hours. The patients were
encouraged to get out of bed and into a chair on the
day of surgery and were allowed to take sips of clear liq-
uids as desired. Intravenous patient-controlled analge-
sia was used as initial pain control. On postoperative
day (POD) 1, the Foley catheter was removed, the
patients were offered a clear liquid diet, the patient-
controlled analgesia was discontinued, oral pain med-
ication was offered, and ambulation was initiated by
exercise specialists. On POD 2, the diet was advanced
to a regular diet as tolerated and ambulation was pro-
gressed. Cathartics were administered if the patient had
not passed flatus or stool per rectum. Subsequent hos-
pital days were a continuation of POD 2 until the
patient was ready for discharge.
Discharge planning. Discharge planning was
initiated on POD 1. The criteria for discharge to
home (beyond being afebrile and hemodynamically
stable) were the toleration of a regular diet with pas-
sage of stool or flatus, independent ambulation, 
and the attainment of preoperative respiratory status.
Furthermore, importantly, the patient was discharged
only when there was agreement between the physi-
cian, the patient, the nursing staff, and the home care-
givers on the timing of the discharge. All the patients
were seen in the office within a week of discharge.
RESULTS
The average LOS of this series of 50 consecutive
patients who underwent infrarenal AS was 3.0 days,
with a range from 2 to 8 days. The average LOS for
the AAA subgroup was 3.2 days and for the ABF sub-
group was 2.8 days. Fifteen patients (30%) were dis-
charged on POD 2, 40 patients (80%) were dis-
charged on or before POD 3, and 48 patients (96%)
were discharged on or before POD 4. The subgroup
of patients (30%) who were discharged on POD 2
represented a slightly younger population (average
age, 60 years) than did the overall group (average
age, 64 years). The average LOS for patients who
underwent AAA repair (3.2 days) was slightly longer
than for the ABF group (2.8 days) and may reflect
the younger age of the ABF group (average age, 60
years) as compared with the AAA group (average age,
69 years). The single emergent operation was per-
formed for an acutely symptomatic, nonruptured
AAA in an 86-year-old man who was discharged on
POD 4. All the patients were discharged to home
without the need for home health services. There
were no readmissions to any healthcare facility with-
in a 30-day period after discharge. There was no
mortality.
Only six patients (12%) were admitted to the
ICU from the PACU for the following reasons: ven-
tilatory support (n = 1), severe chronic obstructive
pulmonary disease (n = 2), severe cardiac disease
that necessitated intravenous nitroglycerine (n = 1),
extreme age of 88 years (n = 1), and emergent oper-
ation that was performed in the evening (n = 1). All
of these patients were transferred the next day, for an
aggregate total of 6 ICU days. No patient was trans-
ferred to the ICU from the floor.
Only two patients (4%) underwent postoperative
nasogastric decompression, and, in both patients, it
was removed on POD 1. In all the patients, a clear
liquid diet was offered on POD 1 and the diet then
was advanced as tolerated. At least 80% of these
patients tolerated a regular diet on or before POD 3
because this was a precondition of discharge.
Evidence of a paralytic ileus was not seen in any
patients.
A combination of this series of 50 patients with
the preceding 50 consecutive patients for AS and an
analysis of this combined series of 100 patients for
AS by quartiles reveal a trend of decreasing LOS.
The first quartile (25 patients) had an average LOS
of 4.5 days, the second of 4.0 days, the third of 3.4
days, and the most recent 25 patients of 2.6 days. In
the first quartile, only one patient (4%) was dis-
charged on POD 2 and 11 patients (44%) were dis-
charged on POD 3, whereas in the most recent
quartile, 11 patients (44%) were discharged on POD
2 and 12 patients (48%) were discharged on POD 3.
DISCUSSION
For patients who undergo infrarenal AS, the two
major prerequisites for discharge are the return of
gastrointestinal function and the ability to ambulate
independently, provided the patient has not had any
significant complications. The sooner these end
points can be reached, the sooner the patient is dis-
charged and the less the hospital-related costs. The
prevailing assumptions relating to AS are that these
patients, by the nature of their associated comorbid
conditions and the characteristics of the surgical pro-
cedures, will have a postoperative course that neces-
sitates admission to the ICU and a postoperative par-
alytic ileus that necessitates gastric decompression.
These assumptions are pervasive and have not been
challenged. The end results of postoperative care on
the basis of these assumptions are the reports of LOS
of 5.9 days,1 6.9 days,2 10.2 days,3 9.9 days,4 6.7
days,5 10.3 days,6 and 8.8 days.7 The LOS of patients
who undergo abdominal AS has not appreciably
changed since the report of Rob8 in 1963 in which
he reported an average LOS of 9.2 days.
First, regarding the necessity for admission to the
ICU, recent reports on AS1-6 uniformly describe the
routine admission of patients to the ICU for a mini-
mum of 24 hours, with the exception of Collier2 who
selectively admitted 86% of his patients to the ICU.
The clinical pathway described in this report calls for a
3-hour period of observation in the PACU and then
transfer to a monitored surgical floor provided that the
patient has undergone extubation and is hemodynam-
ically stable. Forty-four of the 50 patients in this series
(88%) went directly to the floor from the PACU. No
patient who went to the floor was later transferred to
the ICU. Retrospectively, all the patients but one (who
was age 81 and had undergone reoperative AS and
required ventilatory support overnight) could have
been admitted directly to the floor because they all had
undergone extubation and were hemodynamically sta-
ble. However, in practice, patients with a complicated
operative course or those with severe cardiopulmonary
disease are admitted to the ICU to allow closer obser-
vation. This experience with AS suggests that the
admission to the ICU can be safely eliminated in most
patients and that the 3-hour period of observation is
sufficient to detect any postoperative event that would
call for admission to the ICU.
As to the second presumption, the standard 
textbooks of vascular surgery edited by Veith,9 Ruth-
erford,10 Moore,11 and Haimovici12 all describe the
routine use of nasogastric decompression for several
days to treat the “paralytic ileus” that is expected to
follow abdominal AS. Although paralytic ileus may
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be a feature of patients with massive retroperitoneal
hematoma, it does not appear to be prevalent in most
patients after elective AS. Only two patients (4%)
underwent nasogastric decompression after surgery,
each for less than 24 hours. No patient in this series
had a postoperative ileus that necessitated nasogastric
decompression. Most patients were able to take a liq-
uid diet on POD 1, and at least 80% of the patients
tolerated a regular diet on or before POD 3. It
should be noted that, empirically, these patients were
administered metaclopramide (10 mg/intravenous
every 6 hours) after surgery for the first 24 hours to
promote gastric emptying.
A recent paper by Valentine et al13 reports an
overall incidence rate of gastrointestinal complica-
tions of 21% after AS, including a 10% incidence rate
of adynamic ileus that necessitated replacement of
nasogastric tubes. This incidence of adynamic ileus
followed the routine use of postoperative nasogastric
decompression, which was discontinued “usually on
postoperative day 5.”13 The clinical characteristics of
the patients in both Valentine et al’s report and this
study are similar, and it is appropriate to question
whether the routine use of prolonged nasogastric
decompression contributed to the incidence of gas-
trointestinal complications observed.
Consistent with the observations in this series,
the practice of early feeding after major abdominal
gastrointestinal surgery has been extensively report-
ed and has been found to be safe and associated with
decreased hospitalization.14-17 The initiation of
ambulation on POD 1 is also of great importance in
this pathway. The strength and integrity of both the
abdominal wound closure and the arterial anasto-
moses are not enhanced by bed rest, and it is our
clinical observation that early ambulation is well tol-
erated by the patient.
The fact that 80% of these patients were dis-
charged on or before POD 3 and that no patient
required readmission within 30 days shows that once
patients attain the goals of independent ambulation
and toleration of a regular diet they can be safely dis-
charged to home. It is important to emphasize that
these patients are only discharged into an environ-
ment where they initially can be closely attended by
family members, with additional arrangements made
for home care as needed. These results have been
achieved by allowing patients to eat and by encour-
aging ambulation early in the postoperative course
and are not a result of any demonstrable selection
bias. Table II confirms that the clinical characteristics
(age) and risk factors (cardiac disease, diabetes,
hypertension, tobacco use) of this series are compa-
rable with other recently published series for AS. The
success of this pathway is largely dependent on the
acceptance of the physician, the nursing staff, and the
patient of the attainment of the pathway goals and
their cooperative efforts toward these goals.
A formal cost analysis was not performed, and
this must be considered before any definitive conclu-
sions with respect to potential savings are reached.
However, with the exception of the telemetry charge,
the only incremental charge for the patients not
admitted to the ICU was a $220 per diem surcharge
for the specialized nursing unit in one of the hospi-
tals (The Jewish Hospital). Given that the typical per
diem hospital bed charge is approximately $450 and
that an ICU surcharge is approximately $900, the
cost savings are self-evident.
There is much current interest in transluminally
placed endovascular grafts (TPEG) for the treatment
of infrarenal aortic aneurysm. The anticipated
advantages of this approach include a shortened hos-
pital LOS and decreased use of the ICU. Brewster et
al6 have reported a LOS of 3.9 days and an average
ICU stay of 0.1 days for patients who undergo treat-
ment with a TPEG. A recent multicenter clinical trial
of TPEG for AAA has reported an average LOS of
3.8 days, with an average ICU stay of 0.8 days.7 The
series reported here of open surgical procedures,
with an average LOS of 3.0 days and an average ICU
stay of 0.12 days, compares favorably with these
TPEG results.
In summary, these results suggest that the inher-
Table II. Characteristics and risk factors of current series and other recent series
No. Age (years) Cardiac (%) DM (%) HBP (%) Tobacco use (%)
Present series (AAA/ABF) 50 64 48 6 52 74
Valentine et al,13 1998 (AAA/ABF) 120 63 48 15 61 92
Sicard et al,4 1995 (AAA/ABF) 145 65 44 12 57 79
Muluk et al,3 1997 (AAA) 34 72 67 14 58 79
Brewster et al,6 1998 (AAA) 28 73 54 7 46 18
AAA, Abdominal aortic aneurysm repair; ABF, aortobifemoral bypass grafting; DM, diabetes mellitus; HBP, high blood pressure.
ent advantage of the endovascular approach, with
respect to LOS and ICU use, may not be as signifi-
cant as is currently believed. Toward the common
goals of optimizing patient care and eliminating
unnecessary costs, efforts focused at simplifying and
accelerating the postoperative course of patients for
open abdominal AS warrant as much attention as the
efforts to develop the endovascular techniques. As a
closing comment, it would be unreasonable and
inconsistent with the authors’ personal experience
for any individual or institution to implement this
pathway with the expectation that comparable
results will be obtained in rapid order. The results
presented in this report represent all of the incre-
mental gains from a long-standing experience with
the early feeding, early ambulation, and selective use
of the ICU in the postoperative care of the patient
for AS. 
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